Drug Shortage Report for APO-OXCARBAZEPINE

Last updated on 2022-02-09 History
Report ID 118043
Drug Identification Number 02284294
Brand name APO-OXCARBAZEPINE
Common or Proper name OXCARBAZEPINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) OXCARBAZEPINE
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2020-06-16
Estimated end date 2022-03-31
Actual end date 2022-02-08
Shortage status Resolved
Updated date 2022-02-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2022-02-09 English Compare
v18 2022-02-08 French Compare
v17 2022-02-08 English Compare
v16 2021-11-11 French Compare
v15 2021-11-11 English Compare
v14 2021-09-22 French Compare
v13 2021-09-22 English Compare
v12 2021-04-08 French Compare
v11 2021-04-08 English Compare
v10 2020-11-25 French Compare
v9 2020-11-25 French Compare
v8 2020-11-25 English Compare
v7 2020-11-25 French Compare
v6 2020-11-25 English Compare
v5 2020-09-11 French Compare
v4 2020-09-11 English Compare
v3 2020-09-11 English Compare
v2 2020-06-17 French Compare
v1 2020-06-17 English Compare

Showing 1 to 19 of 19